Skip to main content
. 2021 Aug 23;14(1):1959708. doi: 10.1080/16549716.2021.1959708

Table 2.

Deaths and age-standardized mortality rate and percentage change between 1990 and 2017 for genders combined and separated for cardiovascular diseases in Henan

Groups Deaths, in Thousands (95% UIs)
Age-Standardized Mortality Rate (95% UIs),
per 100,000
1990 2017 Percentage Change
(%)
1990 2017 Percentage Change
(%)
Both genders            
Cardiovascular diseases 181(169–194) 375(324–433) 106.9 355(331.6–379.1) 364.1(315.2–417.5) 2.6
Rheumatic heart disease 5(5–6) 3(2–3) −45.0 8.7(7.8–9.7) 2.6(2.2–3) −69.9
Ischemic heart disease 45(41–49) 162(140–187) 258.7 90.3(83.1–98) 161.8(140.4–185.5) 79.2
Stroke 108(101–117) 185(159–214) 71.0 206.9(191.3–222.7) 173.2(149.5–198.9) −16.3
Hypertensive heart disease 19(10–22) 17(13–20) −8.1 40(22.9–48.2) 17.7(12.7–20.9) −55.8
Cardiomyopathy and myocarditis 1(1–1) 1(1–1) 31.4 1.2(1–1.5) 1.1(0.9–1.3) −12.8
Atrial fibrillation and flutter 1(1–1) 3(3–4) 154.2 3.4(2.7–4) 3.6(3.1–4.2) 5.1
Aortic aneurysm 0(0–1) 1(1–1) 92.7 0.8(0.6–1.1) 0.8(0.7–1) −2.2
Peripheral artery disease 0(0–0) 0(0–0) 378.3 0.1(0–0.1) 0.1(0.1–0.3) 115.4
Endocarditis 0(0–0) 0(0–0) 23.8 0.4(0.4–0.5) 0.3(0.3–0.4) −20.0
Non-rheumatic valvular heart disease 0(0–1) 1(0–1) 57.7 0.7(0.5–1.1) 0.5(0.4–0.9) −23.4
Other cardiovascular and circulatory diseases 1(1–2) 2(2–3) 83.5 2.4(1.9–3.1) 2.4(1.9–2.8) −1.9
Males            
Cardiovascular diseases 88(80–96) 199(162–240) 125.8 392.8(360.1–427.8) 423.9(348.6–506) 7.9
Rheumatic heart disease 2(2–2) 1(1–1) −39.9 8(7–9) 2.6(2.1–3.1) −67.8
Ischemic heart disease 24(21–27) 85(69–103) 258.0 105.1(94.6–118.7) 186.3(153.4–223.6) 77.2
Stroke 52(47–58) 101(82–121) 93.0 229.3(208.4–252.5) 206(168.9–245.5) −10.2
Hypertensive heart disease 8(4–10) 8(6–10) 1.5 41.3(23.3–49.3) 19.5(14.1–23.9) −52.7
Cardiomyopathy and myocarditis 0(0–1) 1(1–1) 44.1 1.4(1.1–2) 1.4(1.1–1.9) 0.8
Atrial fibrillation and flutter 0(0–0) 1(1–1) 200.4 2.4(1.7–3.1) 2.7(2.2–3.3) 14.1
Aortic aneurysm 0(0–0) 1(1–1) 106.2 1.3(0.9–1.8) 1.3(1–1.7) 1.5
Peripheral artery disease 0(0–0) 0(0–0) 471.6 0.1(0–0.2) 0.2(0.1–0.4) 148.8
Endocarditis 0(0–0) 0(0–0) 25.9 0.5(0.4–0.6) 0.4(0.4–0.5) −17.7
Non-rheumatic valvular heart disease 0(0–0) 0(0–1) 62.9 0.8(0.6–1.4) 0.6(0.5–1.1) −21.6
Other cardiovascular and circulatory diseases 1(1–1) 1(1–2) 107.3 2.6(1.9–3.6) 2.9(2.2–3.7) 11.0
Females            
Cardiovascular diseases 93(84–103) 176(144–213) 89.0 325.3(294–358.5) 312(255.6–376.1) −4.1
Rheumatic heart disease 3(3–3) 2(1–2) −48.4 9.4(8.2–10.8) 2.7(2.1–3.2) −71.8
Ischemic heart disease 21(19–24) 77(63–93) 259.5 78.3(68.9–87.7) 139.9(114.7–168.2) 78.7
Stroke 56(50–62) 84(68–103) 50.5 190.3(169–211.6) 145.2(118.2–176.8) −23.7
Hypertensive heart disease 10(5–13) 9(5–11) −15.7 38.5(20.6–49.3) 16.1(9.9–20.1) −58.3
Cardiomyopathy and myocarditis 0(0–0) 0(0–0) 15.4 1.1(0.9–1.3) 0.8(0.6–0.9) −25.9
Atrial fibrillation and flutter 1(1–1) 2(2–3) 138.2 4(2.9–4.8) 4.2(3.4–5) 4.0
Aortic aneurysm 0(0–0) 0(0–0) 64.4 0.5(0.3–0.7) 0.4(0.3–0.5) −16.6
Peripheral artery disease 0(0–0) 0(0–0) 294.6 0.1(0–0.1) 0.1(0.1–0.2) 83.2
Endocarditis 0(0–0) 0(0–0) 20.6 0.3(0.3–0.4) 0.2(0.2–0.3) −25.2
Non-rheumatic valvular heart disease 0(0–0) 0(0–0) 52.3 0.6(0.4–1) 0.4(0.3–0.8) −26.1
Other cardiovascular and circulatory diseases 1(0–1) 1(1–1) 59.7 2.2(1.6–3) 1.9(1.5–2.4) −14.4

Note: UIs: Uncertainty Intervals.